Incorporating external controls in the design of randomized clinical trials: a case study in solid tumors.

Autor: Damone EM; Department of Biostatistics, University of North Carolina, 3109 McGavran-Greenberg Hall, CB #7420, Chapel Hill, NC, 27599, USA., Zhu J; Department of Data Science, Product Development, Genentech, Inc, South San Francisco, CA, USA., Pang H; Department of Data Science, Product Development, Genentech, Inc, South San Francisco, CA, USA., Li X; Department of Personalized Healthcare, Product Development, Genentech, Inc, South San Francisco, CA, USA., Zhao Y; Department of Data Science, Product Development, Genentech, Inc, South San Francisco, CA, USA., Kwiatkowski E; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Carey LA; Division of Oncology, University of North Carolina, Chapel Hill, NC, USA., Ibrahim JG; Department of Biostatistics, University of North Carolina, 3109 McGavran-Greenberg Hall, CB #7420, Chapel Hill, NC, 27599, USA. ibrahim@bios.unc.edu.

Publikováno v: BMC medical research methodology [BMC Med Res Methodol] 2024 Nov 01; Vol. 24 (1), pp. 264. Date of Electronic Publication: 2024 Nov 01.

Does walking during chemotherapy impact p16 ^INK4a levels in women with early breast cancer.

Autor: Kammire MS; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Damone EM; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Rosen V; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nyrop KA; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Mitin N; Sapere Bio, Research Triangle Park, North Carolina, USA., Muss HB; School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Dec; Vol. 36 (12), pp. e24753. Date of Electronic Publication: 2022 Nov 06.

Patient-reported treatment toxicity and adverse events in Black and White women receiving chemotherapy for early breast cancer.

Autor: Nyrop KA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA. kirsten_nyrop@med.unc.edu.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. kirsten_nyrop@med.unc.edu., Damone EM; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wheeler SB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Charlot M; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reeve BB; Duke University School of Medicine, Durham, NC, USA., Basch E; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Shachar SS; Department of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Carey LA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Reeder-Hayes KE; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Dees EC; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Jolly TA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kimmick GG; Duke University School of Medicine, Durham, NC, USA., Karuturi MS; MD Anderson Cancer Center, University of Texas, Houston, TX, USA., Reinbolt RE; Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Speca JC; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA., Wood WA; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Muss HB; Division of Oncology, School of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Campus Box 7305, Chapel Hill, NC, 27599-7305, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Jan; Vol. 191 (2), pp. 409-422. Date of Electronic Publication: 2021 Nov 05.

Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy naïve patients with early breast cancer.

Autor: Nakamura ZM; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Deal AM; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nyrop KA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Damone EM; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Muss HB; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Publikováno v: Psycho-oncology [Psychooncology] 2020 Aug; Vol. 29 (8), pp. 1366-1369. Date of Electronic Publication: 2020 Jun 08.